. High-salt diet depresses acetylcholine reactivity proximal to NOS activation in cerebral arteries. Am J Physiol Heart Circ Physiol 283: H353-H363, 2002. First published March 28, 2002 10.1152/ ajpheart.00127.2002-Rats were fed a low-salt (LS; 0.4% NaCl) or high-salt (HS; 4.0% NaCl) diet for 3 days, and the responses of isolated cerebral arteries to acetylcholine (ACh), the nitric oxide (NO)-dependent dilator bradykinin, and the NO donor 6-(2-hydroxy-1-methyl-2-nitrosohydrazino)-N-methyl-1-hex-anamine (NOC-9) were determined. ACh-induced vasodilation and NO release, assessed with the fluorescent NO indicator 4,5-diaminofluorescein (DAF-2) diacetate, were eliminated with the HS diet. Inhibition of cyclooxygenase, cytochrome P-450 epoxygenase, and acetylcholinesterase did not alter ACh responses. Bradykinin and NOC-9 caused a similar dilation in cerebral arteries of all groups. Arteries from animals on LS or HS diets exhibited similar levels of basal superoxide (O 2 Ϫ ) production, assessed by dihydroethidine fluorescence, and ACh responses were unaffected by O 2 Ϫ scavengers. Muscarinic type 3 receptor expression was unaffected by dietary salt intake. These results indicate that 1) a HS diet attenuates ACh reactivity in cerebral arteries by inhibiting NO release, 2) this attenuation is not due to production of a cyclooxygenase-derived vasoconstrictor or elevated O 2 Ϫ levels, and 3) alteration(s) in ACh signaling are located upstream from NO synthase. bradykinin; cyclooxygenase; endothelium; epoxyeicosatrienoic acids; nitric oxide; superoxide RECENT STUDIES INDICATE that a high-salt (HS) diet can impair vessel responses to endothelium-dependent vasodilator stimuli, including acetylcholine (ACh) (4, 15-17, 34, 35, 47). Under normal conditions, ACh-induced dilation may involve the release of several different vasoactive compounds including nitric oxide (NO) (1), endothelium-derived hyperpolarizing factor (EDHF) (6, 28, 30) , and/or cyclooxygenase metabolites of arachidonic acid (25), depending on the specific vessel studied. In cerebral arteries, ACh generally induces vasodilation through a NO-mediated process (9, 41), although there is also evidence suggesting a role for EDHF in ACh-induced dilation of the rabbit middle cerebral artery (49). The extent to which dietary salt may alter the relative contribution of the potential mediators of ACh-induced vasodilation in cerebral arteries remains unknown.
RECENT STUDIES INDICATE that a high-salt (HS) diet can impair vessel responses to endothelium-dependent vasodilator stimuli, including acetylcholine (ACh) (4, 15-17, 34, 35, 47) . Under normal conditions, ACh-induced dilation may involve the release of several different vasoactive compounds including nitric oxide (NO) (1), endothelium-derived hyperpolarizing factor (EDHF) (6, 28, 30) , and/or cyclooxygenase metabolites of arachidonic acid (25) , depending on the specific vessel studied. In cerebral arteries, ACh generally induces vasodilation through a NO-mediated process (9, 41) , although there is also evidence suggesting a role for EDHF in ACh-induced dilation of the rabbit middle cerebral artery (49) . The extent to which dietary salt may alter the relative contribution of the potential mediators of ACh-induced vasodilation in cerebral arteries remains unknown.
The reduced dilation in response to ACh in animals on a HS diet could also result from the liberation of an endothelium-derived contracting factor derived from cyclooxygenase metabolism, as has been reported in some animal models of hypertension (13, 19, 24, 26) . For example, Luscher et al. (37) observed that attenuated dilator responses to ACh in mesenteric resistance vessels of spontaneously hypertensive rats could be partially restored by indomethacin, suggesting that ACh stimulates the release of a constrictor prostanoid, in addition to NO. Other studies have described the effect of a HS diet on the response of arterioles and resistance arteries to NO donors and concluded that NO sensitivity remains unaltered in animals on a HS diet (4, 16, 17, 35, 47) . This suggests that changes in ACh signal transduction occur either at the level of NO synthase (NOS) and/or upstream from the activation of NOS. Finally, Lenda et al. (32) assessed the potential role of O 2 Ϫ in attenuating ACh reactivity in the in situ microcirculation of the spinotrapezius muscle of rats on a HS diet for 4-5 wk. O 2 Ϫ inactivates NO by converting it to peroxynitrite (3), thus inhibiting AChinduced vasodilation. Lenda et al. (32) reported that levels of reactive oxygen species are elevated in the microcirculation of animals on a chronic HS diet and that scavenging of O 2 Ϫ restores the response of arterioles to ACh in the in situ microcirculation. However, the mechanisms responsible for the attenuated vasodilator responses to ACh in normotensive animals on a short-term HS diet are poorly understood.
The overall goal of the present study was to test the hypothesis that short-term exposure to a HS diet impairs ACh-induced vasodilation upstream from NOS. The specific aims of the study were to determine the effect of a short-term HS diet on ACh-induced dilation of rat cerebral arteries, to identify possible changes in the ACh signaling cascade that may contribute to any impaired vascular reactivity observed with a HS diet, and to evaluate the potential role of O 2 Ϫ in contributing to any impaired relaxation to ACh in cerebral resis-tance vessels of animals exposed to short-term elevations in dietary salt intake.
MATERIALS AND METHODS

Animals and preparations.
Age-matched male SpragueDawley rats (Harlan Teklad; Madison, WI) were maintained on a low-salt (LS; 0.4% NaCl) or HS (4.0% NaCl) diet (Dyets; Bethlehem, PA) with tap water ad libitum for 3 days. All rats were housed in an animal care facility at the Medical College of Wisconsin, which is approved by the American Association for the Accreditation of Laboratory Animal Care, and all protocols were approved by the Animal Care Committee at the Medical College of Wisconsin.
On the day of the experiment, rats were anesthetized with pentobarbital sodium (50 mg/kg ip, Abbott Laboratories; Chicago, IL), and a carotid artery was cannulated for determination of arterial pressure. After arterial pressure was measured, the brain was quickly removed and immersed in physiological salt solution (PSS) having the following composition (in mM): 119.0 NaCl, 4.7 KCl, 1.6 CaCl 2, 1.18 NaH2PO4, 1.17 MgSO4, 24.0 NaHCO3, 5.5 dextrose, and 0.03 EDTA. Middle cerebral arteries were carefully isolated using a dissecting microscope (Leica; Buffalo, NY) and cannulated as described below.
Isolated vessel protocol. The isolated vessels were transferred to a superfusion-perfusion chamber and doubly cannulated with glass micropipettes (100-150 m), as described previously (14, 36) . The vessels were continuously perfused and superfused with warmed PSS (37°C) equilibrated with a 21% O 2-5% CO2-74% N2 gas mixture. Intralumenal pressure was set at 80 mmHg for the isolated vessel to approximate the in vivo pressure encountered by the vessel (31, 42) . Internal diameter of the vessel was measured with a video micrometer (model IV-550, FOR.A; Tokyo, Japan). Vessel diameters were measured under resting conditions in PSS and after maximum relaxation of the artery induced by perfusion and superfusion of the vessel with Ca 2ϩ -free PSS having the following composition (in mM): 119.0 NaCl, 20.0 MgCl 2, 4.7 KCl, 1.18 NaH2PO4, 1.17 MgSO4, 24.0 NaHCO3, 5.5 dextrose, and 2.0 EGTA. Any vessel that did not exhibit significant levels of active tone (as evidenced by a substantial increase in resting diameter upon exposure to Ca 2ϩ -free PSS) was not used in this study. Because larger arteries were required for the NO indicator assay (see below), responses to ACh were also evaluated in basilar arteries of rats on LS and HS diets.
Vascular response protocols. To assess potential mediators and modulators of ACh-induced responses in the two groups, ACh concentration-response experiments (10 Ϫ7 -10 Ϫ4 M) were performed before and after removal of the endothelium by air perfusion (14) and in the presence and absence of inhibitors of several vasoactive compounds that have been proposed to contribute to ACh-induced dilation. These included 1) the NOS inhibitor N G -monomethyl-L-arginine (L-NMMA; 10 Ϫ4 M); 2) the cyclooxygenase inhibitor indomethacin (10 Ϫ6 M); and 3) N-methylsulfonyl-6-(2-propargyloxyphenyl)-hexanamide (MS-PPOH; 2 ϫ 10 Ϫ6 M), an irreversible inhibitor of the formation of epoxyeicosatrienoic acids (EETs) (46) , which are putative EDHFs (5). ACh concentration-response experiments were also performed before and after the addition of the acetylcholinesterase inhibitor physostigmine (10 Ϫ5 M) to verify that differences in acetylcholinesterase activity do not modify vascular responses to ACh in middle cerebral arteries obtained from rats on LS or HS diets.
Vessel responses to bradykinin (10 Ϫ10 -10 Ϫ6 M) and 6-(2-hydroxy-1-methyl-2-nitrosohydrazino)-N-methyl-1-hexanamine (NOC-9; a NO donor; 10 Ϫ11 -10 Ϫ5 M) were also recorded in isolated middle cerebral arteries of rats on LS and HS diets. The bradykinin concentration-response experiments were determined before and after the addition of the NOS inhibitor L-NMMA (10 Ϫ4 M) to the tissue bath. To evaluate the potential contribution of reactive oxygen species to the impaired relaxation to ACh in animals on a HS diet, responses of middle cerebral arteries to ACh were also recorded in the presence and absence of either superoxide dismutase (SOD; 80 U/ml, Sigma; St. Louis, MO) and catalase (120 U/ml, Sigma) or polyethylene glycol (PEG)-SOD (250 U/ml, Sigma) and catalase in the perfusion solution. In those experiments, SOD and catalase or PEG-SOD and catalase were added to the perfusate reservoir, and the vessels were incubated for ϳ15 min.
NO indicator assay. ACh-induced NO release was assessed in basilar arteries of rats administered a LS or HS diet using the fluorescent NO indicator 4,5-diaminofluorescein (DAF-2) diacetate (Calbiochem; La Jolla, CA), as described by Kojima et al. (29) and Zhang et al. (51) . DAF-2 diacetate is cell permeable and is hydrolyzed by cytosolic esterases to DAF-2. The relatively nonfluorescent DAF-2 is converted to the highly fluorescent DAF-2 triazole in the presence of NO and oxygen, and the fluorescence intensity of DAF-2 is directly proportional to the NO concentration.
Basilar arteries were selected because the larger internal diameter of these vessels compared with that of middle cerebral arteries facilitates longitudinal sectioning of the vessel, which is necessary to view the endothelium. In these experiments, the arteries were doubly cannulated with glass micropipettes, as described in Isolated vessel protocol. Vessels were flushed with PSS to remove blood cells, sectioned longitudinally, and equilibrated with PSS (37°C) in the vessel chamber for 1 h. Care was taken to ensure that the endothelium remained intact during sectioning. The arteries were then pinned down on a Sylgard (Dow Corning; Midland, MI)-coated dissecting dish with the endothelial surface positioned upward and were submerged in HEPES-buffered PSS having the following composition (in mM): 140 NaCl, 5.4 KCl, 1 MgCl 2, 1.8 CaCl2, 5 HEPES, and 10 glucose. Arteries were incubated with DAF-2 diacetate (10 Ϫ5 M) for 30 min at room temperature and rinsed three times with PSS before experimental observations with an epifluorescence microscope (Nikon E600; Tokyo, Japan) equipped with a ϫ20 objective and 490-nm excitation and 510-to 560-nm emission filters. Digital images were captured using a PC-controlled chargecoupled device camera (Roper Scientific RTE/CCD-1300-Y/ HS; Trenton, NJ) and Metamorph imaging and analysis software (Universal Imaging; Downington, PA).
ACh (10 Ϫ5 M) was added to the basilar artery, and changes in fluorescence were recorded at 5-min intervals for ϳ30 min. An additional group of vessels obtained from rats on a LS diet was incubated with the NOS inhibitor N G -nitro-L-arginine methyl ester (L-NAME; 10 Ϫ4 M) for 15 min before experimental observations and the addition of ACh. The response to the NO donor 1,1-diethyl-2-hydroxy-2-nitrosohydrazine (DEANONOate; 5 ϫ 10 Ϫ4 M) was also evaluated in vessels of animals on either LS or HS diets as a positive control to demonstrate the ability of the DAF-2 assay to increase its fluorescence in response to NO. Responses were expressed as the maximum change in fluorescence intensity after normalization for differences in baseline parameters.
Dihydroethidine assay. On the basis of the procedure described by Bindokas et al. (2), a dihydroethidine (DHEt) assay was used to assess basal O 2 Ϫ production in middle cerebral arteries from rats on short-term LS or HS diets. Hydroethidine combines with O 2 Ϫ , forming fluorescent ethidium, which intercalates with DNA in the cell nucleus. Hydroethidine was purchased from Molecular Probes (Eugene, OR) and dissolved in DMSO (1 g/l). Vessels were placed in petri dishes containing a 10 Ϫ5 M hydroethidine solution in PSS and incubated for 20 min. After incubation, the vessels were removed, rinsed with PSS, and placed on microscope slides for subsequent observation utilizing a confocal microscope. O 2 Ϫ production, as revealed by intensity of fluorescence, was quantified using image analysis software (Metamorph 4.01, Universal Imaging). The mean fluorescence intensity of all stained nuclei in an image was used to assess the average level of O 2 Ϫ production in each treatment group. Fluorescence intensity was estimated for each treatment group and expressed in arbitrary units. To ascertain the effectiveness of the scavengers used in the isolated vessel experiments, a portion of the vessels were incubated with PEG-SOD and catalase in PSS for 15 min before the addition of the hydroethidine solution. The scavengers were added in concentrations comparable to those used in the isolated vessel experiments. As a positive control, 1,1Ј-dimethyl-4,4Ј-bipyridylium dichloride (paraquat; 10 Ϫ4 M, Sigma), a known stimulator of O 2 Ϫ production (11, 20) , was added to middle cerebral arteries from animals on a LS or HS diet to assess the effectiveness of the DHEt assay in detecting O 2 Ϫ . As a negative control, 2.3 ϫ 10 Ϫ5 M Mn(III)tetrakis(4-benzoic acid)porphyrin chloride (MnTBAP; Cayman Chemical; Ann Arbor, MI), a membrane-permeable SOD mimetic (8) , was added to middle cerebral arteries of animals on a LS or HS diet as a further verification of the effectiveness of the DHEt assay.
Western blotting. Muscarinic type 3 (M 3) receptor protein expression was evaluated utilizing a Western blotting protocol modified from Mattson and Higgins (38) . Each experimental group consisted of tissues pooled from four to eight Sprague-Dawley rats fed an acute LS or HS diet. Rats were anesthetized with pentobarbital sodium, and aortas and cerebral vessels (including middle cerebral arteries, basilar arteries, and similar-sized arteries from the Circle of Willis) were freshly dissected and cleared of adhering parenchymal tissue. The vessels were snap-frozen in liquid nitrogen and stored in 0.5-ml microcentrifuge tubes in a freezer (Ϫ85°C) until the time of homogenization. Tissues were subsequently placed in homogenization buffer composed of (in mM) 100 K 2HPO4, 100 KH2PO4, 475 sucrose, 100 EDTA, 1.0 pepstatin, 1.0 leupeptin, and 100 phenylmethylsulfonyl fluoride. Cerebral vessels were hand homogenized in microcentrifuge tubes using a pestle (Kontes; Vineland, NJ). Aortas were homogenized at 3,000 rpm with a Potter-Elvehjem tissue grinder. The homogenates were centrifuged for 20 min at 14,000 g for protein isolation. The supernatant was collected, and the protein content was estimated using a standard protein determination assay (Coomassie Protein Assay, Pierce; Rockford, IL). Fifty micrograms of protein from each sample were suspended in a loading buffer, incubated (10 min at 37°C), and loaded into a single lane of a 10% polyacrylamide gel (Zaxis; Hudson, OH) for electrophoretic separation (200 V, 60 min, Owl Separation Systems; Portsmouth, NH). Kaleidoscope prestained standards (Bio-Rad Laboratories; Hercules, CA) were added into one lane to serve as size standards. The protein was then transferred to a nitrocellulose membrane (100 V, 60 min), washed in Trisbuffered saline (3 times for 10 min), and blocked with 10% nonfat dry milk in Tris-buffered saline for 2 h. A polyclonal antibody specific for the M3 receptor (1:500 dilution in 4% nonfat dry milk in Tris-buffered saline, Santa Cruz Biotechnology; Santa Cruz, CA) was applied to the nitrocellulose membrane for 1 h at room temperature and subsequently conjugated to anti-goat IgG horseradish peroxidase for protein recognition (1:2,500 dilution, 1 h, Santa Cruz Biotechnology). Antibodies were detected using enhanced chemiluminescence (Amersham; Arlington Heights, IL) on X-ray film. Protein expression was evaluated quantitatively using densitometric analysis. After blotting for the M3 receptor, the blot was stripped with a Tris-buffered solution containing 2% sodium dodecyl sulfate and 100 mM ␤-mercaptoethanol at 50°C. After the stripping procedure, the blots were probed with a monoclonal mouse antibody that recognizes ␤-actin (1:1,000 dilution, Sigma) to obtain a loading control.
Data analysis. Vessel responses were described as the change in internal diameter and expressed as means Ϯ SE. A Student's t-test for paired or unpaired data was used to evaluate results in experiments involving single comparisons. All other comparisons were made using ANOVA. The Student-Newman-Keuls test was used for post hoc analysis. A probability value of Ͻ0.05 was considered to be statistically significant. Table 1 provides summary data describing the rats from the different experimental groups employed in this study. The HS diet had no effect on body weight, mean arterial pressure, or vessel diameter.
RESULTS
General characteristics of the experimental groups and response to ACh in animals on HS and LS diets.
In animals on a LS diet, dilation of the middle cerebral artery in response to ACh was endothelium and NOS dependent, because both endothelium denudation and administration of L-NMMA completely eliminated the dilator response (Fig. 1) . Elevated dietary salt intake completely eliminated ACh-induced dilation of isolated middle cerebral arteries and significantly reduced ACh-induced dilation of basilar arteries ( Figs. 1 and 2 ). Resting diameters (208 Ϯ 23 m, n ϭ 5, for LS rats and 208 Ϯ 13 m, n ϭ 5, for HS rats) and maximum diameters (284 Ϯ 15 m, n ϭ 5, for LS Values are means Ϯ SE; n ϭ total number of rats on low-salt (LS) or high-salt (HS) diets. The numbers of vessels for individual studies are indicated in figure legends summarizing the results of the experiments. Shown are the results of studies of the effect of dietary salt intake on the ACh signaling cascade, including body weight, mean arterial pressure (MAP), and internal diameter (ID) of the isolated middle cerebral arteries in physiological salt solution (PSS) and Ca 2ϩ -free PSS.
rats and 290 Ϯ 13 m, n ϭ 5, for HS rats) of the basilar arteries were not affected by dietary salt content. Because some studies have suggested that EDHF could contribute to vasodilation in response to ACh or its analogs in some vessels (5, 6, 28, 30) , and because cyclooxygenase metabolites may contribute to paradoxical vasoconstriction in response to ACh in some models of hypertension (13, 19, 26, 27) , the possible roles of cyclooxygenase metabolites and EETs (as a potential EDHF) in modulating vessel responses to ACh were also evaluated by repeating the ACh concentration-response experiments in the presence of indomethacin or MS-PPOH. The addition of these inhibitors had no significant effect on ACh reactivity regardless of dietary salt intake (Figs. 3 and 4), although indomethacin tended to decrease the resting diameter of arteries from rats on LS and HS diets (data not shown) and reduce the amplitude of the ACh-induced vasodilation in arteries from rats on a LS diet (Fig. 3) . To verify that the impaired responses of vessels from animals on a HS diet were not due to an increased hydrolysis of ACh by acetylcholinesterase, the responses of the arteries from animals on LS or HS diets to ACh were determined before and during treatment of the vessels with the acetylcholinesterase inhibitor physostigmine (10 Ϫ5 M). In those experiments, responses to ACh were unaffected by physostigmine in vessels from animals on either LS or HS diets (data not shown).
Responses to bradykinin and NOC-9. To determine whether the attenuated ACh-induced dilations in arteries of animals on a HS diet are caused by specific changes in ACh reactivity or whether the impaired relaxation to ACh is due to a nonspecific effect of dietary salt intake to reduce the ability of the vessel to relax in response to any vasodilator stimulus, we tested the responses of middle cerebral arteries to bradykinin (an unrelated receptor-mediated vasodilator agonist that releases NO). In those experiments, bradykinin induced a significant, dose-dependent dilation that was similar in magnitude in middle cerebral arteries of rats on both LS and HS diets (Fig. 5) . The Ϫ5 M (ACh) in isolated middle cerebral arteries from rats on short-term low-salt (LS; 0.4% NaCl) or high-salt (HS; 4.0% NaCl) diets (n ϭ 36-39). Responses in each group are compared before and after the addition of N G -monomethyl-L-arginine (L-NMMA; 10 Ϫ4 M, n ϭ 6-11) or before and after removal of the endothelium (n ϭ 5-9). Data are presented as means Ϯ SE. * Significant difference from response of intact untreated vessels of animals on a LS diet, P Ͻ 0.05. bradykinin-induced dilations of the vessels were significantly attenuated by the NOS inhibitor L-NMMA (Fig.  5, inset) .
Additional isolated vessel experiments were performed using the NO donor NOC-9 to determine whether a reduced sensitivity to NO contributed to the attenuated ACh reactivity observed in arteries of rats on a HS diet. NOC-9 caused concentration-dependent dilations that were similar in magnitude in middle cerebral arteries isolated from rats on LS and HS diets (Fig. 6) .
ACh-induced NO release. The fluorescent NO indicator DAF-2 diacetate was used to evaluate the level of ACh-induced NO release in basilar arteries from rats administered LS or HS diets (Fig. 7) . Arteries from rats on a LS diet exhibited a significant increase in NO levels upon stimulation with ACh, and this response was attenuated in vessels from rats on a HS diet. Vessels from rats on a LS diet that were incubated with the NOS inhibitor L-NAME did not exhibit an increase in NO concentration in response to ACh, whereas treatment of the vessels with the NO donor DEANONOate caused a marked increase in DAF-2 fluorescence.
Role of O 2
Ϫ radicals in contributing to impaired dilation in response to ACh in animals on a HS diet. In separate studies, scavengers of reactive oxygen species were added to the isolated arteries to determine whether the attenuated ACh reactivity observed in vessels from animals on a HS diet is due to inactivation of NO by O 2 Ϫ . ACh concentration-response experiments 5 . Dilation of isolated middle cerebral arteries of rats on LS and HS diets in response to increasing concentrations of bradykinin (n ϭ 4-6). Data are presented as means Ϯ SE. There were no significant differences in the response to bradykinin in middle cerebral arteries of rats on HS and LS diets. Inset: response of isolated cerebral arteries of rats on LS and HS diets to bradykinin (n ϭ 11) in the presence and absence of the nitric oxide (NO) synthase inhibitor L-NMMA. L-NMMA significantly attenuated bradykinin-induced vasodilation. * Significant difference from response of control vessels without L-NMMA, P Ͻ 0.05. Fig. 6 . Dilation of isolated middle cerebral arteries from rats on LS (n ϭ 5) and HS (n ϭ 10) diets in response to the NO donor 6-(2-hydroxy-1-methyl-2-nitrosohydrazino)-N-methyl-1-hexanamine (NOC-9). Data are presented as means Ϯ SE. There were no significant differences in the responses to NOC-9 in animals on LS and HS diets.
were performed after incubation of isolated middle cerebral arteries with SOD or PEG-SOD in conjunction with catalase, which have been demonstrated to be effective scavengers of reactive oxygen species in isolated vessel experiments (23, 39, 45) . As expected, ACh caused concentration-dependent increases in vessel diameter in arteries from rats on a LS diet but not those from rats on a HS diet (Fig. 8) . Addition of the O 2 Ϫ scavengers SOD (data not shown) or PEG-SOD (Fig. 8) together with catalase did not restore ACh-induced dilation of arteries from animals on a HS diet.
In another series of experiments, basal O 2 Ϫ production in middle cerebral arteries was assessed using the DHEt assay (Fig. 9) . Under resting conditions, middle cerebral arteries isolated from rats on HS and LS diets exhibited similar levels of fluorescence, indicating comparable amounts of O 2 Ϫ production (Fig. 9, A, B, and F) . The addition of paraquat as a positive control to arteries from animals on either a LS (n ϭ 3) or HS diet (n ϭ 2) significantly increased fluorescence intensity in the DHEt assay, demonstrating that the assay can detect elevated levels of O 2 Ϫ (Fig. 9, C and F, inset) . Incubation with MnTBAP as a negative control reduced O 2 Ϫ levels in middle cerebral arteries of animals on either a LS (n ϭ 3) or HS diet (n ϭ 3) (Fig. 9, D and F, inset) . To verify the efficacy of PEG-SOD and catalase as scav- engers of O 2 Ϫ , middle cerebral arteries were treated with the respective agents and then used in the DHEt assay. PEG-SOD and catalase effectively decreased O 2 Ϫ production in isolated middle cerebral arteries (Fig.  9E ). Dietary salt intake had no effect on the number of observed vascular smooth muscle cell nuclei (data not shown).
Effect of dietary salt intake on M 3 receptor expression. We also evaluated M 3 receptor expression using immunoblot analysis (Fig. 10) to study the potential effect of dietary salt intake on the expression of the ACh receptor responsible for initiating ACh-induced dilation in cerebral arteries. The M 3 receptor is expressed in freshly isolated endothelial cells but is not expressed in cultured endothelial cells (44) . The latter finding suggests that the M 3 receptor is capable of undergoing dramatic changes in protein expression under different experimental conditions. Of particular relevance to this study, loss of the M 3 receptors that are necessary for ACh signal transduction may constitute a potential mechanism for the impaired ACh reactivity observed in arteries of rats on a HS diet. However, arteries from animals on LS and HS diets expressed similar levels of M 3 receptor in the present study (Fig. 10) .
DISCUSSION
Cerebral arteries of rats on a short-term HS diet exhibited attenuated vasodilation to ACh (Figs. 1 and  2 ) despite having similar body weight, mean arterial pressure, and diameter as the control animals on a LS diet (Table 1) . These results are consistent with those of earlier studies showing impaired ACh reactivity in arterioles and skeletal muscle resistance arteries of rats fed an acute HS diet (16, 47) . Together, these findings demonstrate that elevated dietary salt intake leads to impaired ACh-induced dilation in resistance arteries of different vascular beds. Thus loss of vascular relaxation in response to ACh in animals on a HS diet is not restricted to the skeletal muscle circulation but is instead a more generalized phenomenon in the peripheral vasculature.
In the present studies, cerebral arteries of rats on LS and HS diets had identical responses to Ca 2ϩ -free PSS, demonstrating that short-term exposure to a HS diet does not alter resting tone or cause structural remodeling of the middle cerebral artery. This finding is consistent with the lack of structural remodeling of skeletal muscle resistance arteries after short-term exposure to a HS diet (16, 47) but contrasts with the effect of a chronic (4 wk) HS diet on skeletal muscle resistance arteries, where structural remodeling is evident as a decrease in the diameter of the maximally relaxed vessel (15, 47) . Thus the observed alterations in ACh reactivity in cerebral arteries of animals on a HS diet are due to changes in vasodilator pathways rather than the inability of the vessel to increase its diameter due to structural remodeling.
Alterations in ACh reactivity in response to a HS diet could be due to a generalized effect of elevated salt intake to reduce the ability of vessels to relax in response to any vasodilator stimulus. This would presumably result in the attenuation of all receptormediated dilator pathways, including those mediating relaxation in response to ACh. However, bradykinin, an endothelium-dependent dilator that causes NO release through a receptor-mediated signal transduction pathway independent of ACh [bradykinin type 2 (B 2 ) receptors (10, 22) ], caused a similar dilation of middle cerebral arteries from animals on LS and HS diets (Fig.  5) . Of particular interest in this regard is the observation that bradykinin relaxes middle cerebral arteries from animals on a HS diet even though the B 2 receptor operates through a G q protein-mediated pathway (33), similar to ACh. The demonstration of a normal relaxation in response to a receptor-mediated vasodilator agonist other than ACh in arteries from rats on a HS diet suggests that the attenuated ACh reactivity in these animals is due to intrinsic alterations in the ACh pathway and is not due to a nonspecific effect of HS diet to depress all receptor-mediated signaling pathways in the vasculature.
In the present study, ACh reactivity in rat middle cerebral arteries was mediated primarily or entirely by NO, as evidenced by the elimination of the dilator response to ACh in the presence of the NOS inhibitor L-NMMA. The lack of a significant effect of either the cyclooxygenase inhibitor indomethacin (Fig. 3) or MS-PPOH (Fig. 4) (eliminating the potential involvement of EETs in this vascular response) on the response of the vessels to ACh further supports the hypothesis that ACh-induced dilation of the middle cerebral artery is mediated via NO. However, indomethacin treatment also tended to decrease the vasodilator response to ACh in arteries from animals on a LS diet. The latter observation could be consistent with previous reports suggesting that a dilator compound derived from cyclooxygenase may contribute to the vascular response to ACh observed in rats on a standard salt diet (12, 50) but most likely reflects the tendency for resting tone to increase in response to indomethacin due to inhibition of basal prostaglandin production by the endothelium. However, the most important finding from the indomethacin experiments was that the addition of the cyclooxygenase inhibitor did not restore ACh-induced dilation in arteries from rats on a HS diet. The latter observation indicates that elevations in dietary salt intake do not eliminate ACh-induced relaxation by causing the release of a cyclooxygenase-dependent endothelium-derived contracting factor, as reported in certain models of hypertension (26, 27, 37, 40) .
The specific component(s) of the ACh cascade that are altered by an acute HS diet remain unknown. In the present study, the dilation of the cerebral vessels to bradykinin was unaffected by dietary salt intake. Bra- Ϫ levels in rat middle cerebral arteries as assessed using a dihydroethidine (DHEt) assay. Images were displayed using pseudocolor presentation (Metamorph imaging and analysis software).
A-E: representative images of middle cerebral arteries from rats on a LS diet (A) and HS diet (B), a paraquat (PQ)-treated middle cerebral artery from a rat on a HS diet (C), a Mn(III)tetrakis(4-benzoic acid)porphyrin chloride (MnTBAP)-treated artery from a rat on a HS diet (D), and a PEG-SOD-treated artery from a rat on standard chow (E). PQ stimulated O 2 Ϫ production and served as a positive control, whereas MnTBAP, a SOD mimetic, served as a negative control for the DHEt assay. Because O 2 Ϫ levels were similar in vessels from animals on LS and HS diets, data were pooled for the positive and negative controls. Under resting conditions, fluorescence intensity, expressed in AU, was similar in middle cerebral arteries from rats on LS (n ϭ 11) and HS (n ϭ 11) diets (F). Inset, positive and negative controls (n ϭ 4-6). Data are presented as means Ϯ SE. * Significant difference from fluorescence intensity of PEG-SOD-and MnTBAPtreated arteries, P Ͻ 0.05. See text for details.
dykinin-induced dilation was significantly attenuated by L-NMMA (Fig. 5, inset) , demonstrating that NO release plays a major role in the relaxation of the vessels in response to the agonist. The absence of an impaired response to bradykinin in arteries of animals on a HS diet indicates that NOS function is intact in the vessels and that loss of the vasodilator response to ACh in arteries of animals on a HS diet is not due to an inability of the enzyme to catalyze the formation of NO in these animals.
In the present study, we observed that basilar arteries of rats on a HS diet, which exhibited an impaired dilation in response to ACh (Fig. 2) , also exhibited an attenuated release of NO in response to ACh, as revealed by decreased DAF-2 fluorescence (Fig. 7) . The latter observation strongly indicates that the impaired dilation that occurs in response to ACh in cerebral arteries of rats on a HS diet is due to attenuated NO release.
A reduced sensitivity of the vascular smooth muscle cells to the vasodilator effect of NO could also contribute to the impaired relaxation of the vessel in response to ACh in arteries of animals on a HS diet. To determine whether a decreased sensitivity of the vascular smooth muscle cells to NO could contribute to the reduced dilation in response to ACh in middle cerebral arteries of animals on a HS diet, we tested the effect of increasing concentrations of the NO donor NOC-9 on vessel diameter (Fig. 6) . Consistent with the results of several previous studies (4, 16, 17, 35, 47) , arteries from animals on LS and HS diets exhibited a similar dilation in response to the NO donor, suggesting that vascular sensitivity to NO is unaltered by elevated dietary salt intake.
Experimental evidence obtained from in vivo studies of skeletal muscle arterioles suggests that the attenuated ACh reactivity observed in rats on a chronic HS diet may be due to an elevated production of O 2 Ϫ , resulting in inactivation of NO (32) . The present study specifically tested the hypothesis that O 2 Ϫ impairs NO mediated dilation of middle cerebral arteries using two techniques: evaluation of basal O 2 Ϫ levels in the vessels using the DHEt assay and measurement of ACh responses in isolated arteries incubated with O 2 Ϫ scavengers. The results of those experiments suggest that O 2 Ϫ levels are similar in arteries obtained from animals on LS and HS diets and that inactivation of NO by reactive oxygen species is not responsible for the impaired ACh reactivity occurring in cerebral arteries of animals on a short-term HS diet (Figs. 8 and 9 ).
Although the administration of O 2 Ϫ scavengers restores ACh reactivity in spinotrapezius arterioles of animals on a chronic HS diet (32) , neither SOD plus catalase nor PEG-SOD plus catalase restored AChinduced dilation in middle cerebral arteries from rats on a HS diet. However, this does not preclude a role for radicals in altering agonist-induced reactivity in other physiological and experimental conditions, because multiple factors have been implicated in the modulation of vascular control mechanisms by O 2 Ϫ (23). Differences in vascular networks, levels of salt intake, duration of exposure to a HS diet, or the presence or absence of blood and parenchymal cells may account for differences in the effect of free radical scavengers on ACh-induced dilation of vessels in this study compared with earlier findings in the in vivo microcirculation of skeletal muscle (32) .
On the basis of the findings of this study, we postulate that the impaired relaxation in response to ACh that occurs in middle cerebral arteries from animals on a HS diet is due to alterations in the ACh cascade upstream from NOS. One possible mechanism for a reduced relaxation to ACh would be the loss of the M 3 receptor responsible for initiating the signaling cascade. The M 3 receptor is the mediator of ACh-induced vasodilation (7, 21, 43) , and its expression is downregulated in certain experimental models, including cultured endothelial cells (44) . However, M 3 receptors were still expressed in cerebral arteries of both groups of animals, and the level of expression was unaffected by dietary salt intake (Fig. 10) .
The finding that M 3 receptors are still expressed in cerebral arteries of animals on a HS diet indicates that the impaired ACh reactivity in the cerebral vasculature during elevated salt intake is not due to M 3 receptor downregulation. However, it does not preclude changes in receptor affinity or receptor desensitization as possible mechanisms resulting in attenuated AChinduced vasodilation. Wu et al. (48) reported that M 3 receptors possess a phosphorylation site for G proteincoupled receptor kinase 2 that may be responsible for regulating M 3 signal transduction, and such a mechanism could lead to receptor desensitization in animals on a HS diet. We believe that a more likely explanation for the altered response to ACh in vessels from animals on a HS diet may be an uncoupling of the muscarinic receptor from the G q protein, precluding it from increasing intracellular Ca 2ϩ concentration in the endothelial cells. The latter hypothesis is supported by recent studies suggesting that impaired coupling between membrane receptors and G proteins may be responsible for the reduced responses to some vasodilator agonists in skeletal muscle resistance arteries from rats administered acute or chronic HS diets (18, 47) . However, further investigation is required to determine the role of these possible mechanisms in mediating impaired vascular relaxation during elevated dietary salt intake.
In conclusion, middle cerebral arteries from rats fed a short-term HS diet exhibit attenuated dilator responses to ACh, and ACh-induced dilation and NO release are also attenuated in basilar arteries of rats on a HS diet. However, vascular responses to bradykinin, another NO-dependent vasodilator agonist, and to the NO donor NOC-9 remain intact, suggesting that the downstream components of the ACh cascade and vascular sensitivity to NO are unaffected by a HS diet. In contrast to the studies of Lenda et al. (32) , short-term exposure to elevated dietary salt intake does not appear to elevate O 2 Ϫ levels in rat middle cerebral arteries, and O 2 Ϫ does not appear to be responsible for the attenuated ACh reactivity in the present studies. Taken together, the results of this study indicate that the impaired relaxation in response to ACh in vessels of animals on a HS diet is due to alterations in the ACh signaling cascade that lie upstream from endothelial NOS.
